Neoleukin Therapeutics Inc (NASDAQ:NLTX)

0.8038
Delayed Data
As of Jun 02
 -0.0142 / -1.74%
Today’s Change
0.38
Today|||52-Week Range
1.34
+57.92%
Year-to-Date

Stock Price Forecast

The 1 analysts offering 12-month price forecasts for Neoleukin Therapeutics Inc have a median target of 1.50, with a high estimate of 1.50 and a low estimate of 1.50. The median estimate represents a +86.61% increase from the last price of 0.80.

Analyst Recommendations

The current consensus among 2 polled investment analysts is to Hold stock in Neoleukin Therapeutics Inc. This rating has held steady since March, when it was unchanged from a Hold rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.10
Sales
$0.00
Reporting Date
Aug 16

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 56.82%
 
 
 
 
 
 
Growthannually 53.37%
 
 
 
 
 
 

Sales

Growthquarterly --
Growthannually --
Key to the earnings and sales forecast charts.